NCT06703515

Brief Summary

This is a prospective randomised controlled trial conducted at two tertiary referral hospitals in Hong Kong to compare the clinical and functional outcomes of office-based awake transnasal laser-assisted laryngeal surgery (TNLS) under local anesthesia to traditional microlaryngeal surgery for vocal cord cyst under general anesthesia.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
21mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Dec 2024Dec 2027

First Submitted

Initial submission to the registry

November 11, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

3.1 years

First QC Date

November 11, 2024

Last Update Submit

November 20, 2024

Conditions

Keywords

Vocal cord cystTransnasal laser surgeryMicrolaryngeal surgeryOffice based laser surgeryAwake laser laryngeal surgeryTrublue laser

Outcome Measures

Primary Outcomes (1)

  • Voice-Handicap Index (VHI-30)

    The primary outcome was to compare the pre- and post-operative Voice-Handicap Index 30 (VHI-30) of TNLS and MLS groups. The VHI-30 is a 30-item self-administered questionnaire, with score range from 0 to 120, and a score of 120 meaning worst voice score. It has been shown to be a reliable measure for voice treatment outcome. It consists of three subscales, namely physical, functional and emotional. It provides an overall measurement of a person's vocal function and how it influences a person's everyday functioning and experience.

    From enrolment to post-operative 1year

Secondary Outcomes (16)

  • Perceptual evaluation of voice

    From enrolment to post-operative 1year

  • Acoustic voice analysis - Noise-to-Harmonic ratio (NHR)

    From enrolment to post-operative 1year

  • Acoustic voice analysis - Jitter

    From enrolment to post-operative 1year

  • Acoustic voice analysis - Shimmer

    From enrolment to post-operative 1year

  • Aerodynamic measure of voice

    From enrolment to post-operative 1year

  • +11 more secondary outcomes

Study Arms (2)

Microlaryngeal surgery (MLS)

ACTIVE COMPARATOR

For traditional MLS under general anesthesia, after general anesthesia and intubation with microlaryngeal tube, the patient would be positioned on head-ring support for better alignment and access to glottis. A laryngoscope will be inserted transorally under direct vision and suspended. Vocal cord cysts are visualized with microscope, and removed with microsurgery instruments with microflap technique and sent for routine section. After the surgery, the patient is kept nil-by-mouth until fully awake, and is discharged on same day or the next day depending on the post- operative recovery. Patient will be discharged with voice rest for 3 days.

Procedure: Microlaryngeal surgery (MLS)

Awake transnasal laser-assisted surgery (TNLS)

EXPERIMENTAL

For TNLS, patients are admitted to the day center on the same morning or afternoon of the surgery with fasting prior 6 hours. After local anesthesia application, a 445nm blue laser is introduced via a working channel of bronchoscope and laser ablation of vocal cord cyst is performed. During the operation, patient will receive continuous SpO2 monitoring with regular blood pressure monitoring. After the procedure, patients are kept nil-by-mouth for 2 hours until anesthesia wears off, meanwhile with close observation in day ward with continuous SpO2 monitor for 1 hour. Patients will be discharged on the same day of the procedure, with voice rest for 3 days.

Procedure: Awake transnasal laser-assisted surgery (TNLS)

Interventions

For TNLS, patients are admitted to the day center on the same morning or afternoon of the surgery with fasting prior 6 hours. After local anesthesia application, a 445nm blue laser is introduced via a working channel of bronchoscope and laser ablation of vocal cord cyst is performed. During the operation, patient will receive continuous SpO2 monitoring with regular blood pressure monitoring. After the procedure, patients are kept nil-by-mouth for 2 hours until anesthesia wears off, meanwhile with close observation in day ward with continuous SpO2 monitor for 1 hour. Patients will be discharged on the same day of the procedure, with voice rest for 3 days.

Awake transnasal laser-assisted surgery (TNLS)

For traditional MLS under general anesthesia, after general anesthesia and intubation with microlaryngeal tube, the patient would be positioned on head-ring support for better alignment and access to glottis. A laryngoscope will be inserted transorally under direct vision and suspended. Vocal cord cysts are visualized with microscope, and removed with microsurgery instruments with microflap technique and sent for routine section. After the surgery, the patient is kept nil-by-mouth until fully awake, and is discharged on same day or the next day depending on the post- operative recovery. Patient will be discharged with voice rest for 3 days.

Microlaryngeal surgery (MLS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with vocal cord cysts
  • older than 18-year-old
  • able to independently provide consent
  • able to tolerate flexible laryngoscopy would be recruited

You may not qualify if:

  • under 18-year-old
  • unable to independently give an informed consent
  • unable to tolerate flexible laryngoscopy
  • allergic to local anesthesia
  • had unfavorable anatomy such as prolapsing epiglottis precluding adequate visualization, extensive lesions and an expected difficult operation as judged by the surgeons
  • with pathologies other than vocal cord cyst

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Location

Related Publications (11)

  • Misono S, Yueh B, Stockness AN, House ME, Marmor S. Minimal Important Difference in Voice Handicap Index-10. JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1098-1103. doi: 10.1001/jamaoto.2017.1621.

    PMID: 28973078BACKGROUND
  • Ng E, Law T, Tang EC, Ho FN, Tong MC, Lee KY. The Cutoff Point and Diagnostic Accuracy of the Voice Handicap Index in Cantonese-Speaking Population. J Voice. 2021 Mar;35(2):163-168. doi: 10.1016/j.jvoice.2020.09.021. Epub 2020 Oct 9.

    PMID: 33046276BACKGROUND
  • Gao WZ, Abu-Ghanem S, Reder LS, Amin M, Johns MM. A Novel Approach to Vocal Fold Mucous Retention Cysts: Awake KTP Laser-Assisted Marsupialization. J Voice. 2022 Jul;36(4):570-573. doi: 10.1016/j.jvoice.2020.07.028. Epub 2020 Aug 22.

    PMID: 32843259BACKGROUND
  • Gocal WA, Tong JY, Maxwell PJ, Sataloff RT. Systematic Review of Recurrence Rates of Benign Vocal Fold Lesions Following Surgery. J Voice. 2025 May;39(3):787-798. doi: 10.1016/j.jvoice.2022.10.015. Epub 2022 Dec 10.

    PMID: 36513559BACKGROUND
  • Hsu CM, Armas GL, Su CY. Marsupialization of vocal fold retention cysts: voice assessment and surgical outcomes. Ann Otol Rhinol Laryngol. 2009 Apr;118(4):270-5. doi: 10.1177/000348940911800406.

    PMID: 19462847BACKGROUND
  • Courey MS, Gardner GM, Stone RE, Ossoff RH. Endoscopic vocal fold microflap: a three-year experience. Ann Otol Rhinol Laryngol. 1995 Apr;104(4 Pt 1):267-73. doi: 10.1177/000348949510400402.

    PMID: 7717615BACKGROUND
  • Tam AKY, Leung NMW, Lee SKJ, Wei Y, Hu Y, Chan JYK, Law T. Randomized Controlled Trial of Awake Transnasal Laser-Assisted Surgery for Benign Laryngeal Lesions. Laryngoscope. 2024 Aug;134(8):3732-3740. doi: 10.1002/lary.31481. Epub 2024 May 10.

    PMID: 38727019BACKGROUND
  • Schimberg AS, Wellenstein DJ, van den Broek EM, Honings J, van den Hoogen FJA, Marres HAM, Takes RP, van den Broek GB. Office-based vs. operating room-performed laryngopharyngeal surgery: a review of cost differences. Eur Arch Otorhinolaryngol. 2019 Nov;276(11):2963-2973. doi: 10.1007/s00405-019-05617-z. Epub 2019 Sep 5.

    PMID: 31486936BACKGROUND
  • Lin YH, Wang CT, Lin FC, Liao LJ, Lo WC, Cheng PW. Treatment Outcomes and Adverse Events Following In-Office Angiolytic Laser With or Without Concurrent Polypectomy for Vocal Fold Polyps. JAMA Otolaryngol Head Neck Surg. 2018 Mar 1;144(3):222-230. doi: 10.1001/jamaoto.2017.2899.

    PMID: 29346486BACKGROUND
  • Wellenstein DJ, Honings J, Schimberg AS, Schutte HW, Herruer JM, van den Hoogen FJA, Takes RP, van den Broek GB. Office-based CO2 laser surgery for benign and premalignant laryngeal lesions. Laryngoscope. 2020 Jun;130(6):1503-1507. doi: 10.1002/lary.28278. Epub 2019 Sep 9.

    PMID: 31498454BACKGROUND
  • Shoffel-Havakuk H, Sadoughi B, Sulica L, Johns MM 3rd. In-office procedures for the treatment of benign vocal fold lesions in the awake patient: A contemporary review. Laryngoscope. 2019 Sep;129(9):2131-2138. doi: 10.1002/lary.27731. Epub 2018 Dec 21.

    PMID: 30575043BACKGROUND

Central Study Contacts

Aurora KY Tam, MBBS, MRCSEd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 11, 2024

First Posted

November 25, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

November 25, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations